Key result
An LVEF ≤35% was associated with a higher 5-year risk of fatal arrhythmic events compared to an LVEF >45% in Japanese patients with coronary artery disease.
Why the study?
Fatal arrhythmic events are devastating complications in CAD, prompting an assessment of their incidence in more recent Japanese CAD patients and whether risk stratification remains feasible using LVEF.
Cohort (n=25,843)
Yes
Answers are grounded in this paper and cite their sources.
Left ventricular ejection fraction remains a strong independent predictor of fatal arrhythmic events in patients with coronary artery disease undergoing revascularization.
BACKGROUND: Fatal arrhythmic events (FAEs), such as sudden cardiac death (SCD) and fatal ventricular arrhythmias, are a devastating complication in patients with coronary artery disease (CAD). Therefore, in this study we aimed to assess the incidence of FAEs in more recent Japanese patients with CAD and to examine whether risk stratification of FAEs can still be feasible using the left ventricular ejection fraction (LVEF). METHODS AND RESULTS: In the CREDO Kyoto PCI/CABG registry cohorts-2 and -3, there were 25,843 patients with LVEF data who received a first coronary revascularization (LVEF ≤35% group: N=1,671, 35% 45%: N=21,503). FAEs were defined as a composite of SCD or hospitalization for serious ventricular arrhythmias. The cumulative 5-year incidence of FAEs was 2.4% and it increased with decreasing LVEF (LVEF ≤35%: 8.84%, 35% 45%: 1.67%, log-rank P<0.0001). The adjusted risk of FAEs also increased with decreasing LVEF. CONCLUSIONS: LVEF is still a strong independent factor for predicting FAEs in patients with CAD in the PCI era. There was no obvious decrease in the incidence of FAEs between the 2 cohorts. The risk factors for FAEs through the 2 cohorts, other than low LVEF, included age ≥75 years, diabetes, heart failure, hemodialysis, atrial fibrillation, and anemia.
No takes yet. Share an insight, caveat, or question.
Hanazawa et al. (2025) conducted a cohort in Coronary artery disease (n=25,843). Left ventricular ejection fraction (LVEF) ≤35% vs. LVEF >45% was evaluated on Fatal arrhythmic events (composite of sudden cardiac death, hospitalization for serious ventricular arrhythmia, and appropriate ICD shocks) (HR 3.18, 95% CI 2.47-4.09, p=<0.0001). An LVEF ≤35% was associated with a higher 5-year risk of fatal arrhythmic events compared to an LVEF >45% in Japanese patients with coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: